Machery Nagel

Since 1911 MACHEREY-NAGEL represents high quality,innovation, and reliability in biomolecular and chemical innovation, and reliability in biomolecular and chemical the cornerstones of our corporate success for over 100 years.The family-owned business is being run by the fourth generation.

View as

Sort by

Display per page

SPE Chromab. columns Drug, 1 mL, 100 mg, 100 730681

CHROMABOND columns Drug volume: 1 mL, content of sorbent: 100 mg material: PP, with PE-filterelements pack of 100

SPE Chromab. columns Drug, 3 mL, 200 mg 730168

CHROMABOND columns Drug volume: 3 mL, content of sorbent: 200 mg material: PP, with PE-filterelements pack of 50

SPE Chromab. columns Drug, 3 mL, 500 mg, 50 730684

CHROMABOND columns Drug volume: 3 mL, content of sorbent: 500 mg material: PP, with PE-filterelements pack of 50

SPE Chromab. columns Drug, 6 mL, 500 mg, 30 730682

CHROMABOND columns Drug volume: 6 mL, content of sorbent: 500 mg material: PP, with PE-filterelements pack of 30

SPE Chromab. columns Easy, 1 mL, 100 mg, PP 730752

CHROMABOND columns EASY volume: 1 mL, content of sorbent: 100 mg material: PP, pack of 30

SPE Chromab. columns Easy, 1 mL, 30 mg, PP 730751

CHROMABOND columns EASY volume: 1 mL, content of sorbent: 30 mg material: PP, pack of 30

SPE Chromab. columns Easy, 15 mL, 1000 mg,PP 730758

CHROMABOND columns EASY volume: 15 mL, content of sorbent: 1000 mg material: PP, pack of 20

SPE Chromab. columns Easy, 15 mL, 500 mg, PP 730757

CHROMABOND columns EASY volume: 15 mL, content of sorbent: 500 mg material: PP, pack of 20

Machery Nagel

SPE Chromab. columns Drug, 1 mL, 100 mg, 100 730681

SPE Chromab. columns Drug, 3 mL, 200 mg 730168

SPE Chromab. columns Drug, 3 mL, 500 mg, 50 730684

SPE Chromab. columns Drug, 6 mL, 500 mg, 30 730682

SPE Chromab. columns Easy, 1 mL, 100 mg, PP 730752

SPE Chromab. columns Easy, 1 mL, 30 mg, PP 730751

SPE Chromab. columns Easy, 15 mL, 1000 mg,PP 730758

SPE Chromab. columns Easy, 15 mL, 500 mg, PP 730757

Information

Customer service

My account

Follow us